Penryn Surgery Holdings Limited 08394362 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is activities of head offices. Digita Accounts Production Advanced 6.30.9574.0 true false false 08394362 2025-04-01 2026-03-31 08394362 2026-03-31 08394362 core:CapitalRedemptionReserve 2026-03-31 08394362 core:RetainedEarningsAccumulatedLosses 2026-03-31 08394362 core:ShareCapital 2026-03-31 08394362 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 08394362 core:Non-currentFinancialInstruments 2026-03-31 08394362 core:Non-currentFinancialInstruments core:AfterOneYear 2026-03-31 08394362 bus:SmallEntities 2025-04-01 2026-03-31 08394362 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 08394362 bus:FullAccounts 2025-04-01 2026-03-31 08394362 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 08394362 bus:RegisteredOffice 2025-04-01 2026-03-31 08394362 bus:Director1 2025-04-01 2026-03-31 08394362 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 08394362 countries:England 2025-04-01 2026-03-31 08394362 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 08394362 2024-04-01 2025-03-31 08394362 2025-03-31 08394362 core:CapitalRedemptionReserve 2025-03-31 08394362 core:RetainedEarningsAccumulatedLosses 2025-03-31 08394362 core:ShareCapital 2025-03-31 08394362 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 08394362 core:Non-currentFinancialInstruments 2025-03-31 08394362 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 08394362

Penryn Surgery Holdings Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2026

 

Penryn Surgery Holdings Limited

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Penryn Surgery Holdings Limited

(Registration number: 08394362)
Abridged Balance Sheet as at 31 March 2026

Note

2026
£

2025
£

Fixed assets

 

Investments

4

524,398

524,398

Current assets

 

Debtors

158,394

155,409

Cash at bank and in hand

 

31

27

 

158,425

155,436

Creditors: Amounts falling due within one year

(2,100)

(1,800)

Net current assets

 

156,325

153,636

Total assets less current liabilities

 

680,723

678,034

Creditors: Amounts falling due after more than one year

(76,440)

(76,440)

Net assets

 

604,283

601,594

Capital and reserves

 

Called up share capital

76,440

76,440

Capital redemption reserve

2,421

2,421

Profit and loss account

525,422

522,733

Total equity

 

604,283

601,594

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

Penryn Surgery Holdings Limited

(Registration number: 08394362)
Abridged Balance Sheet as at 31 March 2026

Approved and authorised by the Board on 15 October 2026 and signed on its behalf by:
 

Dr K Sanders

Director

 

Penryn Surgery Holdings Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 15 October 2026.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

 

Penryn Surgery Holdings Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2025 - 7).

4

Investments

Total
£

Cost or valuation

At 1 April 2025

524,398

Provision

Carrying amount

At 31 March 2026

524,398

At 31 March 2025

524,398